Being Persuasive via Video: Best Practice in Video Conferencing in Europe and US
Craig Svobod, Global Head of IP, Alvotech
Andras Kupecz, Partner, Pinsent Masons (NED)
Address IP Challenges in the Pharmaceutical AI World
Jason Rice, Patent Attorney, GSK
Matt Hervey, Head of Artificial Intelligence Law, Gowling WLG (UK)
Pete Sadler, Partner, Reddie & Grose (UK)
Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?
Brian Coggio, Attorney, Fish & Richardson (USA)
Adrian Chew, Senior Associate, Bristows LLP (UK)
Daan De Laange, Partner, Brinkhof (NED)
Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG
Daniel Lim
Strategic Consideration for Patent Portfolio Litigation
Mark van Gardingen, Partner, Brinkhof
Kristin Cooklin, Head of Intellectual Property, Zentiva
Dr Inga- Marlene Pietsch, Principal Associate, Gowling WLG (GBR)
Discovering New Frontier for Second Medical Use Patent
Nitika Gupta Fiorella, Principal, Fish & Richardson (USA)
Tjibbe Douma, Partner, Bird & Bird (NED)
Tessa M. Malamud-Cohen, Director, Patents, Global Intellectual Property, Ferring Pharmaceuticals
Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG
Establishing a Successful Cross Border Relief Strategy
Cecile Teles, Head of Patent Attorney, Zentiva
Ricardo Dijkstra, Partner, Vondst (NED)
Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?
Rieke Kaup, DG Competition, European Commission
Sara Burghart, Lead IP Litigation Counsel – Global Litigation & Launch, Sandoz
Corinna Sundermann, Senior Vice President Intellectual Property, Fresenius Kabi Deutschland
Moderator: Stephan Neuhaus, Partner, Allen & Overy (DEU)
